We next examined the combination therapy of JNK-in-IX and the standard chemotherapeutic regimen for human pancreatic cancer cell lines, FOLFIRINOX and Gemcitabine-Paclitaxel (Gem-Pac). The gene discussed is MAPK8; the disease is familial pancreatic carcinoma.